Attendee List released for Biosimilars and Biobetters | Network with Sandoz, Boehringer Ingelheim, Sanofi, Teva, Mundipharma International, AbbVie, Orion Corporation and more

Top Quote SMi's Biosimilars and Biobetters conference, taking place on 30 September - 1 October 2015 in London, will address pharmacovigilance of biosimilars, patent litigation, market access, product commercialisation barriers and global market developments. End Quote
  • (1888PressRelease) September 11, 2015 - In just 3 weeks, SMi will open its doors to the 6th annual Biosimilars and Biobetters conference. The two-day event will provide the ideal platform to engage in scientific discussions and debate the best practices and solutions to improve industry performance. As well as learning from your peers through case studies and interactive debate, don't miss the opportunity to hear from specialists representing big pharma, academia and biotech, for important updates in the field.

    Is your name on the list? Download the 2015 attendee list to take a look at who you can network with at http://www.biosimilars-biobetters.co.uk/1888pressrelease

    Featured Speakers include:
    Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals USA, Inc. (he's dropped out and unity's updated)
    Shahin Kauser, Senior Scientific Assessor, MHRA
    Chris Teale, Vice President Europe, GfK NOP Ltd
    Bracha Timan, Director, Israel Site Head, Global Bioassays & Technology, Global R&D, Teva
    Takashi Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences
    Karsten Roth, Director Clinical Operations, Cinfa Biotech GmbH
    Alan Sheppard, Principal, Global Generics and Biosimilars, IMS Health
    Steinar Madsen, Medical Director, Norwegian Medicines Agency

    View the full speaker line-up, complete two-day conference programme and download the event brochure at http://www.biosimilars-biobetters.co.uk/1888pressrelease

    Why do I need to be there?
    Hear the latest on the evolving regulatory landscape for biosimilars and review the guidelines
    Gain understanding on the barriers being faced for market access and commercialisation of products through case-study led presentations
    Focus on the global market developments with case studies on emerging markets of biosimilars and examine the trends we are currently seeing
    Assess and review in-depth protein characterisation and analytical comparability to efficiently and effectively collect data

    Plus, don't miss two interactive conference workshops:
    Workshop A | 1:00pm - 5.30pm | 29th September 2015
    Assessing the Regulatory Framework for Europe and the US - Developing Future Biologics
    Workshop Leaders: Lincoln Tsung, Daniel Kracov, Jennifer Sklenar, Partners, Arnold & Porter (UK) LLP

    Workshop B | 8:30am - 12.30pm | 2nd October 2015
    Biosimilars - Understanding the Regulatory Processes and the Commercial Realities
    Workshop Leader: Peter Wittner, Senior Consultant, Interpharm Consultancy

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information
  • Vinh Trinh
  • Smi Group
  • Unit 122/124 Great Guildford Business Square, 30 Great Guildford Street, London
  • SE1 0BS
  • Voice: 44 (0) 20 7827 6140
  • Visit our Site